Takeda and Insilico Partner on $600M AI-Driven Drug Discovery Deal
Takeda and Insilico Medicine Forge Major AI Drug Discovery Partnership
Takeda Pharmaceuticals has entered into a significant collaboration with Insilico Medicine, a clinical-stage generative artificial intelligence company specializing in AI-driven drug discovery. The partnership, valued at up to $600 million, represents a substantial investment in the intersection of pharmaceutical research